DSM-Firmenich AG - Company Profile

Powered by

All the data and insights you need on DSM-Firmenich AG in one report.

  • Save hours of research time and resources with
    our up-to-date DSM-Firmenich AG Strategy Report

  • Understand DSM-Firmenich AG position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

DSM-Firmenich AG (DSM-Firmenich) is a science-based company with focus on identifying environmental, social challenges and opportunities, then it captures such opportunities to create long-term positive impact on people and planet, finally it focuses on building growth through long-term, performance driven profitable growth. The company produces vitamins, carotenoids, nutritional lipids and other ingredients; specialty plastics; and fiber and resin solutions. The company develops materials for medical devices and clean energy from crop residues and bio-chemicals. The company’s businesses are closely aligned with its customers to facilitate rapid. development of impactful science-bases innovations. The company has operations in Eastern Europe, Latin America, North America, Asia Pacific and other regions. DSM-Firmenich is headquartered in Kaiseraugst, Switzerland.

Gain a 360-degree view of DSM-Firmenich AG and make more informed decisions for your business Gain a 360-degree view of DSM-Firmenich AG and make more informed decisions for your business Find out more
Headquarters Switzerland

Address Wurmisweg 576, Kaiseraugst, 4303


Industry Chemicals

Ticker Symbol & Exchange DSFIR (AMS)

EPS XYZ

Net Income (2023) XYZ 25.7% (2023 vs 2022)

Market Cap* $29.2B

Net Profit Margin (2023) XYZ -0.7% (2023 vs 2022)

* As of and is in US$
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

DSM-Firmenich AG premium industry data and analytics

8

IT Services Contracts

Improve competitive bidding with insights into all publicly disclosed IT services contracts for DSM-Firmenich AG (including IT outsourcing, business process outsourcing, systems integration & consulting and more).

Products and Services

Products Services Brands
ABS Polymer Custom Manufacturing Services AgiSyn
Active Ingredients Akulon
Additives ALPAFLOR
XYZ XYZ
XYZ XYZ
XYZ XYZ
Understand DSM-Firmenich AG portfolio and identify potential areas for collaboration Understand DSM-Firmenich AG portfolio and identify potential areas for collaboration Find out more

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2024 Divestiture In March, the company sold DSM Jiangshan Pharmaceutical to Jingjiang Cosfocus Health Technology Co., Ltd.
2024 Contracts/Agreements In February, the company entered into a partnership with Zerion Pharma to enhance the bioavailability of cannabinoids.
2023 Regulatory Approval In December, the company received market authorization for Bovaer in the UK.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Find out more
Image for loader

Competitor Comparison

Key Parameters DSM-Firmenich AG BASF SE Solvay SA Akzo Nobel NV Novozymes AS
Headquarters Switzerland Germany Belgium Netherlands Denmark
City Kaiseraugst Ludwigshafen Am Rhein Bruxelles Amsterdam Bagsvaerd
State/Province - Rheinland-Pfalz Bruxelles-Capitale - -
No. of Employees - 111,991 22,000 35,200 6,397
Entity Type Public Public Public Public Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Geraldine Matchett Chief Financial Officer; Co-Chief Executive Officer Senior Management 2020 51
Dimitri de Vreeze Co-Chief Executive Officer; Chief Operating Officer Senior Management 2021 56
Katharina Stenholm Chief Sustainability Officer Senior Management 2023 -
Patricia Malarkey Chief Innovation Officer Senior Management 2019 -
Thomas Leysen Chairman Non Executive Board 2021 63
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into DSM-Firmenich AG key executives to enhance your sales strategy Gain insight into DSM-Firmenich AG key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Why are you leaving?